Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in Mice and Ferrets (Q30396758)

21 June 2017

title

Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets (English)

1 reference

21 June 2017

Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in Mice and Ferrets (English)

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.026

4 September 2024

0 references

1 reference

PengHui Yang

1

1 reference

21 June 2017

YueQiang Duan

2

1 reference

21 June 2017

Cheng Wang

3

1 reference

21 June 2017

Li Xing

4

1 reference

21 June 2017

Xiao Gao

5

1 reference

21 June 2017

Chong Tang

6

1 reference

21 June 2017

DeYan Luo

7

1 reference

21 June 2017

ZhongPeng Zhao

8

1 reference

21 June 2017

Weihong Jia

9

1 reference

21 June 2017

Daxin Peng

10

1 reference

21 June 2017

Xiufan Liu

11

1 reference

21 June 2017

Xiliang Wang

12

1 reference

21 June 2017

language of work or name

English

0 references

publication date

25 November 2010

1 reference

full work available at URL

21 June 2017

https://api.elsevier.com/content/article/PII:S0264410X1001635X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.026

https://api.elsevier.com/content/article/PII:S0264410X1001635X?httpAccept=text/plain

4 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.026

4 September 2024

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

698-705

1 reference

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Questioning the timeline of H1N1 flu vaccination contracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Vaccinate before the next pandemic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

The development of live attenuated cold-adapted influenza virus vaccine for humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Rescue of influenza B virus from eight plasmids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Reverse genetics of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Swine flu outbreak. China first to vaccinate against novel H1N1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

China boosts pandemic surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Response of BALB/c mice to a monovalent influenza A (H1N1) 2009 split vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Strategies for developing vaccines against H5N1 influenza A viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Reverse Genetics for the Control of Avian Influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Animal models for the preclinical evaluation of candidate influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Human infection with highly pathogenic H5N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.026

Equine influenza: A review of an unpredictable virus

7 January 2021

5

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.026

4 September 2024

Identifiers

1 reference

21 June 2017

1 reference